Anti-obesity therapy: from rainbow pills to polyagonists
TD Müller, C Clemmensen, B Finan, RD DiMarchi… - Pharmacological …, 2018 - ASPET
With their ever-growing prevalence, obesity and diabetes represent major health threats of
our society. Based on estimations by the World Health Organization, approximately 300 …
our society. Based on estimations by the World Health Organization, approximately 300 …
An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action
RP Shank, JF Gardocki, AJ Streeter, BE Maryanoff - Epilepsia, 2000 - Wiley Online Library
In this overview, we discuss the discovery and development of topiramate (TPM) as an
anticonvulsant, including notable aspects of its chemical, biologic, and pharmacokinetic …
anticonvulsant, including notable aspects of its chemical, biologic, and pharmacokinetic …
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial
BA Johnson, N Ait-Daoud, CL Bowden… - The Lancet, 2003 - thelancet.com
Background Topiramate, a sulphamate fructopyranose derivative, might antagonise
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …
alcohol's rewarding effects associated with abuse liability by inhibiting mesocorticolimbic …
Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity
The current obesity pandemic results from a physiological imbalance in which energy intake
chronically exceeds energy expenditure (EE), and prevention and treatment strategies …
chronically exceeds energy expenditure (EE), and prevention and treatment strategies …
Topiramate for treating alcohol dependence: a randomized controlled trial
BA Johnson, N Rosenthal, JA Capece, F Wiegand… - Jama, 2007 - jamanetwork.com
ContextHypothetically, topiramate can improve drinking outcomes among alcohol-
dependent individuals by reducing alcohol's reinforcing effects through facilitation of γ …
dependent individuals by reducing alcohol's reinforcing effects through facilitation of γ …
Narrative review of topiramate: clinical uses and pharmacological considerations
NZ Pearl, CP Babin, NT Catalano, JC Blake… - Advances in …, 2023 - Springer
Due to the diverse mechanisms of action of antiseizure drugs, there has been a rise in
prescriptions of these drugs for non-epileptic pathologies. One drug that is now being used …
prescriptions of these drugs for non-epileptic pathologies. One drug that is now being used …
Centrally acting agents for obesity: past, present, and future
AA Coulter, CJ Rebello, FL Greenway - Drugs, 2018 - Springer
For many years, obesity was believed to be a condition of overeating that could be resolved
through counseling and short-term drug treatment. Obesity was not recognized as a chronic …
through counseling and short-term drug treatment. Obesity was not recognized as a chronic …
Drug interactions at GABAA receptors
ER Korpi, G Gründer, H Lüddens - Progress in neurobiology, 2002 - Elsevier
Neurotransmitter receptor systems have been the focus of intensive pharmacological
research for more than 20 years for basic and applied scientific reasons, but only recently …
research for more than 20 years for basic and applied scientific reasons, but only recently …
[HTML][HTML] Molecular mechanisms of antiseizure drug activity at GABAA receptors
LJ Greenfield Jr - Seizure, 2013 - Elsevier
Abstract The GABA A receptor (GABA AR) is a major target of antiseizure drugs (ASDs). A
variety of agents that act at GABA A Rs s are used to terminate or prevent seizures. Many act …
variety of agents that act at GABA A Rs s are used to terminate or prevent seizures. Many act …
Carbonic anhydrase inhibitors and epilepsy: State of the art and future perspectives
Carbonic anhydrases (CAs) are a group of ubiquitously expressed metalloenzymes that
catalyze the reversible hydration/dehydration of CO2/HCO3. Thus, they are involved in those …
catalyze the reversible hydration/dehydration of CO2/HCO3. Thus, they are involved in those …